SCNI vs T · P/E 0.2, rev $1.3M vs P/E 7.4, rev $63.06B
Scinai Immunotherapeutics Ltd (SCNI) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the SCNI and T stock pages for the full models.
Not investment advice.